DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20201645

A randomised controlled trial on effect of splinting a joint on the lifespan of intravenous cannula in pediatric patients

Murali B. H., Abirami Meenakshi Chandrasekaran, Meghana Nannapaneni

Abstract


Background: Children admitted to hospital and ICUs for various reasons like sepsis, respiratory distress, dehydration, shock etc. require an intravenous line for medications and IV fluids. Properly securing an intravenous line is very important. It is equally important to maintain the patency of the intravenous line for longer periods of time. But there is no adequate data regarding factors affecting the duration of patency of an IV line. This study was done to compare effect of limb splinting versus non-splinting with the functional duration of peripheral IV cannula.

Methods: This study was done over 3 months between October - December 2018 in pediatric patients (age 6 months to 5 years) admitted to Kempegowda Hospital. Patients were randomised into splint group and non-splint group. In the splint group a firm splint was applied to the joint that was cannulated. No such intervention was done in the non-splint group. Time from IV line placement to removal was measured.

Results: Total 438 patients were taken into study. After exclusion 200 patients were given a splint and 200 were not splinted. The median survival time was more in splint group when compared to non-splint group.

Conclusions: This study shows that splinting helps to maintain patency of IV line for a more longer duration than non splinting of the joint.


Keywords


Extravasation, Intravenous cannula, Splint

Full Text:

PDF

References


Garber A, Klein E, Bruce S, Sankoh S, Mohideen P. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy. Diabetes Obes Metab. 2006;8(2):156-63.

O'Brien C. Drug addiction and drug abuse. In: Brunton LB, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill; 2005:607-629.

National Cancer Institute. Fact sheet: targeted cancer therapies, 2012. Available at: http://www.cancer.gov/cancertopics/factsheet/Therapy/targeted#q1. Accessed 9 June 2014.

Pettit J. Assessment of the infant with a peripheral intravenous device. Adv Neonatal Care. 2003;3(5):230-40.

Bilal S. Question 1: does use of a splint increase the functional duration of cannulae in neonates? Arch Dis Childhood. 2014;99(7):694-5

Tripathi S, Kaushik V, Singh V. Peripheral IVs. J Infus Nurs. 2008;31(3):182-8.

Gupta P, Rai R, Basu S, Faridi M. Life span of peripheral intravenous cannula in a neonatal intensive care unit of a developing country. J Pediatr Nurs. 2003;18(4):287-92.

Dalal S, Chawla D, Singh J, Agarwal R, Deorari A, Paul V. Limb splinting for intravenous cannulae in neonates: a randomised controlled trial. Arch Dis Childhood - Fetal Neonatal Ed. 2009;94(6):F394-6.

Raghavan M, Praveen BK. Effect of joint immobilization on the lifespan of intravenous cannula: a randomised controlled trial. Int J Contemp Pediatr. 2015;2:411-14.

August D, Ullman AJ, Rickard CM, New K. Peripheral intravenous catheter practices in Australian and New Zealand neonatal units: A cross-sectional survey. J Neonatal Nursing. 2019;25.